Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q1 Loss
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q1 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.